Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023 16:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Tony Bihl, interim chief executive officer,...
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
August 08, 2023 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
August 04, 2023 08:30 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief...
Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023
August 01, 2023 17:35 ET
|
Bioventus, Inc.
DURHAM, N.C., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Completes Divestiture of its Wound Business
May 23, 2023 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., May 23, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has...
Bioventus Reports First Quarter Financial Results
May 16, 2023 16:15 ET
|
Bioventus, Inc.
DURHAM, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
May 15, 2023 17:33 ET
|
Bioventus, Inc.
DURHAM, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will now report...
Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023
May 11, 2023 07:00 ET
|
Bioventus, Inc.
DURHAM, N.C., May 11, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the Company plans to...
Bioventus Announces Divestiture of its Wound Business
May 10, 2023 09:00 ET
|
Bioventus, Inc.
DURHAM, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has signed a...
Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
May 03, 2023 08:30 ET
|
Bioventus, Inc.
DURHAM, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...